SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ATIS is on the move!
ATIS 0.1000-47.4%Apr 14 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Marshall Teitelbaum who wrote (1679)10/22/1998 8:01:00 AM
From: Dr. Bob  Read Replies (2) of 2205
 
LIFC may be trying a flanking strategy on the insurance companies, with its "micronized" product, which could be injected. This presumably could replace collagen injections in the sizeable plastic/cosmetic surgery field, for which most customers pay out of pocket. Does ATIS have a similar product/ambitions?

LIFC has also been moving up of late, possibly secondary to favorable mentions, but maybe the sector as a whole, or small caps as a group are finally gaining favor (I think the latter explanation is most likely).

Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext